REVITALIZE Summit, Celebrating 30 years of Females in Clinical Trials
June 28 @ 11:00 am - 5:00 pm EDT
Join FemHealth Insights for a 1-day virtual Revitalize Summit to explore the role of government in the advancement of women’s health. Hear from industry leaders on the present state and future of clinical trial development and analysis, alternative forms of research funding, and reimbursement strategies with payors and federally funded programs.
Through keynotes, panels, and networking, explore how technological advancements are changing the way healthcare for females is built, delivered, and reimbursed.
Who is attending? This is a great event for anyone working in or interested in women’s health from pharma, biotech, academia, regulatory, media, venture capital, family offices, foundations, startups, US Government, payors, and the like.
Why is it called Revitalize? Between 1977 and 1993, females of reproductive age were banned from participating in clinical trials in the United States. Luckily, Congress passed the NIH Revitalization Act in 1993 which reversed this ban and permitted female participation. This change was absolutely critical for the next wave of femhealth research and innovation.